Free the Data!
Please consider submitting BRCA1/2 testing results from your patients to www.sharingclinicalreports.org.
See: http://nyti.ms/14hUJsu for an explanation of the issue.
Thank you, Your GeneDx Team
RET Remaining Exons Sequencing (MEN2B)
FORMS AND DOCUMENTS
TEST DETAILS
- Genes:
- RET
- Disorders:
- Clinical Utility:
-
- Confirmation of a clinical diagnosis
- Development of a screening program for the associated malignancies
- Identification of at-risk family members
- Prenatal diagnosis
- Lab Method:
- Capillary Sequencing
ORDERING
- Test Code:
- 1792
- Turnaround Time:
- 4-5 weeks
- Preferred Specimen:
- 2-5 mL Blood - Lavender Top Tube
BILLING
- CPT Codes:
- 81479x1
- List Price:
- $1,750.00
- Billing Information:
- View Billing Policy
- ICD Codes:
-
- 193: Malignant neoplasm of thyroid gland, Thyroglossal duct
- 255.6: Medulloadrenal hyperfunction, Catecholamine secretion by pheochromocytoma
- 191.9: Brain, unspecified Cranial fossa NOS
REFERENCES
- Eng, C. et al., Point mutation within the tyrosine kinase domain of the RET-proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet. 3: 237-41, 1994
- Gimm, O. et al., Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab. 82: 3902-4, 1997
- Dr. Charis Eng, personal communication, 2004
